LUNESTA
Identification of Lunesta
| No description |
Google image searchProduct monograph
Active ingredient
eszopiclone, 2 MG
DIN: 02453215
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: SUMITOMO PHARMA CANADA, INC.
Date: 18-APR-2024
ATC:
- N05 — PSYCHOLEPTICS (ATC, ATC/DDD, )
- N05C — HYPNOTICS AND SEDATIVES (ATC, ATC/DDD)
- N05CF — Benzodiazepine related drugs (ATC, ATC/DDD)
- N05CF04 — ESZOPICLONE (ATC/DDD)
Pharmaceutical standard: USP
